Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Debrisoquine sulfate

Known as: DEBRISOQUIN SULFATE 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2000
2000
Debrisoquine (D), an antihypertensive drug metabolized to 4-hydroxydebrisoquine (4-OHD) by CYP2D6, is commonly used as an in vivo… Expand
1986
1986
Central dopaminergic (DA) function in children was assessed by monitoring plasma-free homovanillic acid (pHVA) levels after brief… Expand
1986
1986
The total 24 hour urinary outputs of the catecholamines norepinephrine (NE), epinephrine (E), dopamine (DA) and the DA metabolite… Expand
1982
1982
Morphine withdrawal behavior, brain and plasma catecholamine metabolites, and brain beta-noradrenergic receptor binding were… Expand
Highly Cited
1980
Highly Cited
1980
Abstract Metabolites of catecholamine neurotransmitters in plasma are, potentially, an easily available indicator of brain… Expand
Highly Cited
1980
Highly Cited
1980
The extent to which debrisoquine (D) is metabolized to 4-hydroxydebrisoquine (4OHD) was found to be influenced by the ethnic… Expand
1975
1975
A high proportion of an oral dose of 14C-debrisoquine sulfate is excreted in the urine by rat and man. The urinary radioactivity… Expand
1969
1969
The responses of the human eye to the intraocular administration of the adrenergic neurone blocking drugs guanethidine sulfate… Expand
1968
1968
Sixty-three hypertensive patients were treated with debrisoquin sulfate, a new sympathetic blocking drug, for periods of 6 to 33… Expand
1966
1966
Debrisoquin sulfate is a moderately potent antihypertensive agent with a predominant orthostatic antihypertensive action. The… Expand